Bioregenx Income Statement (2022-2026) | BRGX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.01M0.01M0.01M0.01M1.08M0.88M0.79M0.68M0.55M0.73M0.60M0.46M0.52M0.45M0.51M0.39M0.43M
Cost of Revenue (Quarter) 0.31M0.26M0.22M0.30M0.17M0.26M0.11M0.14M0.11M0.09M0.08M0.07M0.08M
Gross Profit (Quarter) 0.76M0.60M0.57M0.38M0.38M0.47M0.48M0.32M0.41M0.35M0.43M0.32M0.35M
Operating items
Amortization - Intangibles (Quarter) 0.00M0.00M0.00M0.00M0.00M0.50M0.56M0.56M0.56M-0.03M
Selling, General & Administrative (Quarter) 0.77M1.00M2.96M0.49M3.41M1.40M0.24M1.87M0.59M0.46M0.43M0.55M0.40M
Restructuring Costs (Quarter) 0.01M0.01M0.01M0.01M0.01M0.00M0.00M0.01M
Other Operating Expenses (Quarter) 0.04M0.04M0.01M0.01M0.17M0.14M0.08M0.09M0.05M0.11M0.57M16.77M0.01M0.00M0.00M0.70M0.00M
Operating Expenses (Quarter) 0.05M0.05M0.01M0.01M0.95M1.14M3.04M0.59M3.46M1.51M0.81M18.64M0.60M0.46M0.43M1.25M0.40M
Operating Income (Quarter) -0.04M-0.03M-0.00M-0.01M-0.18M-0.54M-2.47M-0.21M-3.08M-1.04M-0.33M-18.32M-0.19M-0.11M-0.01M-0.94M-0.05M
EBIT (Quarter) -0.05M
Non-operating items
Non Operating Income (Quarter) -0.07M0.02M
Other Non Operating Income (Quarter) 0.08M
Net income details
EBT (Quarter) -0.13M
Profit After Tax (Quarter) -0.03M
Income from Continuing Operations (Quarter) -0.13M
Consolidated Net Income (Quarter) -0.13M
Income towards Parent Company (Quarter) -0.13M
Net Income towards Common Stockholders (Quarter) -0.13M
Additional items
EPS (Basic) (Quarter) 0.00
EPS (Weighted Average and Diluted) (Quarter) 0.00
Shares Outstanding (Weighted Average) (Quarter) 969.17M
Shares Outstanding (Diluted Average) (Quarter) 969.17M
EBITDA (Quarter) -0.03M
Interest Expenses (Quarter) 0.08M